Company Overview

KURA ONCOLOGY, INC.

KURA
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
67M
2025 FY
Net Income
-279M
2025 FY
Shares Outstanding
88M
2025 FY
EPS
-3.18USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1422143
Exchange
Nasdaq
Location
US